Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Track-and-Trace Law: Push Begins For 2015 Exchange Standards

This article was originally published in The Pink Sheet Daily

Executive Summary

FDA has a tight deadline to finalize guidance on transaction information.

You may also be interested in...



FDA’s Hand-Held Rx Counterfeit Detector Could Roll Out To Developing Nations

Agency meets with USAID stakeholders and wants to maximize the public health impact of its hand-held counterfeit drug detection device, which allows for quick preliminary screening of drug shipments to determine if counterfeit or adulterated product is present.

Track-and-Trace Deal Chances Trending Up

GPhA head says Congress remains committed to passing its preferred lot-level tracking proposal and leadership in both congressional chambers will find a vehicle, possibly to get it passed during the upcoming lame-duck session.

Track-and-Trace Deal’s Failure Leaves California In Control Of Agenda

Industry groups will continue to search for legislative vehicles to move a national standard that would preempt state laws; near-term, though, manufacturers and distributors must prepare for California pedigree law.

Related Content

Topics

UsernamePublicRestriction

Register

PS075067

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel